ZA200208271B - Chromenylmethyl pyrimidinediamines as antibacterial agents. - Google Patents

Chromenylmethyl pyrimidinediamines as antibacterial agents. Download PDF

Info

Publication number
ZA200208271B
ZA200208271B ZA200208271A ZA200208271A ZA200208271B ZA 200208271 B ZA200208271 B ZA 200208271B ZA 200208271 A ZA200208271 A ZA 200208271A ZA 200208271 A ZA200208271 A ZA 200208271A ZA 200208271 B ZA200208271 B ZA 200208271B
Authority
ZA
South Africa
Prior art keywords
dimethyl
chromen
ylmethyl
methoxy
compound
Prior art date
Application number
ZA200208271A
Other languages
English (en)
Inventor
Peter Mohr
Philippe Pflieger
Original Assignee
Basilea Pharmaceutica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica Ag filed Critical Basilea Pharmaceutica Ag
Publication of ZA200208271B publication Critical patent/ZA200208271B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C07F7/0814Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring said ring is substituted at a C ring atom by Si
ZA200208271A 2000-04-27 2002-10-14 Chromenylmethyl pyrimidinediamines as antibacterial agents. ZA200208271B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00108945 2000-04-27

Publications (1)

Publication Number Publication Date
ZA200208271B true ZA200208271B (en) 2004-01-26

Family

ID=8168565

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200208271A ZA200208271B (en) 2000-04-27 2002-10-14 Chromenylmethyl pyrimidinediamines as antibacterial agents.

Country Status (14)

Country Link
US (1) US6818649B2 (ko)
EP (1) EP1278742B1 (ko)
JP (1) JP4033676B2 (ko)
KR (1) KR20020093966A (ko)
CN (1) CN1249057C (ko)
AT (1) ATE284882T1 (ko)
AU (1) AU2001252269A1 (ko)
BR (1) BR0110255A (ko)
CA (1) CA2405614A1 (ko)
DE (1) DE60107832T2 (ko)
ES (1) ES2232614T3 (ko)
MX (1) MXPA02010518A (ko)
WO (1) WO2001083476A1 (ko)
ZA (1) ZA200208271B (ko)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI243173B (en) 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
AU2004278414B2 (en) * 2003-10-01 2012-05-24 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
ATE451381T1 (de) * 2005-01-19 2009-12-15 Rigel Pharmaceuticals Inc Prodrugs aus 2,4-pyrimidindiamin-verbindungen und ihre verwendungen
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
EP1770089A1 (en) * 2005-10-03 2007-04-04 Institut Pasteur Pyranodibenzofuran derivatives with antifungal and antibacterial activity
US7855194B2 (en) 2006-03-27 2010-12-21 Hoffmann-La Roche Inc. Pyrimidine, quinazoline, pteridine and triazine derivatives
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
CN109134493A (zh) * 2018-09-19 2019-01-04 浙江师范大学 一种具有抗菌活性的2-氧代色烯并噻吩衍生物及其合成方法和应用
CN109988156B (zh) * 2019-03-12 2021-12-28 广东中科药物研究有限公司 一种氨基嘧啶化合物
CN112824412B (zh) * 2019-11-21 2022-09-16 中国科学院大连化学物理研究所 手性1′H-螺[吲哚啉-3,4′-吡喃并[2,3-c]吡唑]-2-酮类化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020839A1 (en) * 1995-12-04 1997-06-12 F. Hoffmann-La Roche Ag Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial

Also Published As

Publication number Publication date
EP1278742A1 (en) 2003-01-29
CA2405614A1 (en) 2001-11-08
BR0110255A (pt) 2003-01-07
CN1507445A (zh) 2004-06-23
KR20020093966A (ko) 2002-12-16
MXPA02010518A (es) 2003-03-10
DE60107832T2 (de) 2005-06-16
ES2232614T3 (es) 2005-06-01
ATE284882T1 (de) 2005-01-15
JP2004509839A (ja) 2004-04-02
US20030144246A1 (en) 2003-07-31
EP1278742B1 (en) 2004-12-15
CN1249057C (zh) 2006-04-05
AU2001252269A1 (en) 2001-11-12
DE60107832D1 (en) 2005-01-20
US6818649B2 (en) 2004-11-16
WO2001083476A1 (en) 2001-11-08
JP4033676B2 (ja) 2008-01-16

Similar Documents

Publication Publication Date Title
AU2015284135B2 (en) Heteroaryl compounds useful as inhibitors of SUMO activating enzyme
JP6453845B2 (ja) Brd4阻害薬としてのジヒドロキナゾリノン類似体
JP3117721B2 (ja) 新規なベンジルピリミジン類
KR101626627B1 (ko) 아미도-티오펜 화합물 및 이의 용도
US20090209554A1 (en) Thiazoliums as transketolase inhibitors
CZ2002534A3 (cs) Inhibitory protein-kináz, farmaceutické prostředky, které je obsahují, a jejich pouľití
TW201838966A (zh) 取代的二氫茚-4-甲醯胺及其類似物以及其使用方法
WO2009046416A1 (en) Anilinopyrimidines as jak kinase inhibitors
WO2007126128A1 (ja) ジヒドロピラゾロピリミジノン誘導体
KR20130135826A (ko) Aids를 치료하기 위한 나프트-2-일아세트산 유도체
CN106573930B (zh) 作为smac模拟物的6-炔基-吡啶衍生物
ZA200208271B (en) Chromenylmethyl pyrimidinediamines as antibacterial agents.
JPH10508587A (ja) ロイコトリエン生合成阻害剤としてのビスアリールカルビノールケイ皮酸
NZ766447A (en) Prc2 inhibitors
SA04250088A (ar) مركبات كيميائية
EP3884939A1 (en) 3-phosphoglycerate dehydrogenase inhibitors and uses thereof
TWI508968B (zh) 用於治療呼吸道融合性病毒感染的化合物
US9126972B2 (en) 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors
MXPA02004443A (es) 5-bencil-2,4-diaminopirimidinas sustituidas.
AU2013326408A1 (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses
WO2016204135A1 (ja) 5員ヘテロ環誘導体
MXPA02010517A (es) Derivados de indol-pirimidinil-metil con actividad antibacteriana.
GB2080301A (en) Substituted Pyrimidin-2-ones, the Salts thereof, Processes for their Preparation and Pharmaceutical Compositions Containing them